Previous 10 | Next 10 |
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial results for the quarter and full year ended December 31, 2021 on Thursday, March 10, 2022. Neovasc's President and Chief Executive Officer Fred Colen, a...
VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - February 08, 2022 - Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced the German Institute for the Hospital Remuneration System ("InEK") has awarded the Neovasc Reducer™ ("Reducer"...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 4, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (Neovasc or the Company) today announced the publication of cost-effectiveness studies supporting the use of the Neovasc ReducerTM ("Re...
VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - January 20, 2022 - Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced the publication of an article entitled, “The Effectiveness of CS Reducer for the Treatment of Refrac...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - January 20, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (Neovasc or the Company) today announced the publication of an article entitled, "The Effectiveness of CS Reducer for the Treatment of Refractory...
VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - January 18, 2022 - Neovasc Inc. (“Neovasc” or the “Company”) ( NASDAQ , TSX : NVCN) today announced the publication of a case series in the journal Cardiovascular Revasc...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - January 18, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced the publication of a case series in the journal Cardiovascular Revascularization Medicin e desc...
VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - January 06, 2022 - Neovasc, Inc. (“Neovasc” or the “Company”) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the 2022 H.C. Wainwright BIOCONNECT Virtual Con...
COSIRA-II Trial Designed to Study the Neovasc Reducer(TM) for Patients with Refractory Angina Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - January 5, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced enrollment of the f...
Presentation Times Released for 75+ Presenting Companies Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day December Micro Cap Virtual Conference takin...
News, Short Squeeze, Breakout and More Instantly...
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...